MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    Diagnostic Utility of Blood α-Synuclein in Parkinson’s Disease: A Systematic Review and Meta-analysis

    D. Su, L. Luo, J. Lam, T. Feng (Beijing, China)

    Objective: The aims were to (1) explore the concentration differences of α-syn species in different blood components between PD and healthy controls (HC), and between…
  • 2023 International Congress

    Validity and reliability of muscle peak power testing in persons with Parkinson’s disease

    F. Jensen, M. Langeskov-Christensen, L. Hvid, U. Dalgas (Aarhus, Denmark)

    Objective: We investigated the construct and ecological validity ON medication and the test-retest reliability both ON and OFF medication of the linear encoder lower extremity…
  • 2023 International Congress

    The incidence of Parkinson’s disease in Nigeria: a systematic review and meta-analysis

    A. Memudu, E. Ekhoye (Iyamho, Nigeria)

    Objective: The study aim to integrate various investigations pertaining to the incidence of Parkinson's disease (PD) in Nigeria, with the objective of comprehensively characterizing the…
  • 2023 International Congress

    Apathy correlated with motor and non-symptoms in de-novo patients with Parkinson’s disease

    S. Lee, S. Jo, J. Lee, S. Chung (Seoul, Republic of Korea)

    Objective: We aimed to investigate how the severity of apathy affects motor symptom and other non-motor symptoms in patients with de-novo Parkinson’s disease (PD). Background:…
  • 2023 International Congress

    The impact of biographic factors and lifestyle on the symptoms of Parkinson’s Disease – a five year follow-up

    J. Stögbauer, A. Bär, L. Schappe, U. Hillmann, K. Fassbender, C. Dupeyrat, D. Martens, J. Spiegel (Homburg, Germany)

    Objective: To identify biographic parameters that may have an impact on the different symptoms of parkinson’s disease. Background: Parkinson’s disease (PD) is a neurodegenerative movement…
  • 2023 International Congress

    Estrogen derivatives and hydrogen peroxide as promising biomarkers in parkinson’s disease-preliminary results

    J. Sławek, P. Bastian, A. Roszmann, J. Dulski, D. Jacewicz, J. Drzezdzon, A. Kuban-Jankowska, M. Wozniak, N. Knap, T. Bączek, L. Konieczna, M. Belka, M. Gorska-Ponikowska (Gdańsk, Poland)

    Objective: The study aimed to identify biomarkers of early-stage neurodegeneration in Parkinson’s disease (PD). Background: The currently available diagnostic clinical criteria for PD enable diagnosis…
  • 2023 International Congress

    Diagnostic accuracy of susceptibility map-weighted MRI for discriminating tremor-dominant Parkinson’s disease and essential tremor

    MK. Yoon, S. Jo, S. Lee, J. Lee, CH. Suh, SJ. Chung (Seoul, Republic of Korea)

    Objective: We investigated the diagnostic accuracy of nigrosome using susceptibility map-weighted imaging (SMwI) in distinguishing tremor-dominant Parkinson's disease (PD) and essential tremor (ET). Background: Tremor is…
  • 2023 International Congress

    Protective potential of laughter yoga and clapping exercise on stress level and motor functions in Parkinson’s disease patients with type 2 diabetes

    R. Singh, V. Sharma (Delhi, India)

    Objective: To examine the protective potential of laughter yoga and clapping exercise on blood glucose regulation on stress level and motor functions of PD patients…
  • 2023 International Congress

    Effect of Sex on the association between GBA mutations and Cognitive Decline in Parkinson’s Disease

    SP. Caminiti, M. Avenali, M. Inglese, C. Tassorelli, D. Perani (Pavia, Italy)

    Objective: To assess the impact of sex and glucocerebrosidase (GBA) mutations on cognitive trajectories in a sample of Parkinson's disease (PD) patients. Background: Accumulating evidence…
  • 2023 International Congress

    Free-viewing eye tracking in Parkinson’s disease and correlation with clinical features

    A. Gallagher, H. Elliott, J. Inocentes, B. Coe, D. Brien, B. White, H. Riek, R. Walsh, T. Lynch, R. Reilly, D. Munoz, C. Fearon (Dublin 7, Ireland)

    Objective: The objective of our study is to determine whether differences in saccade amplitude/velocity in combination with pupillary dynamics and blink rate in a cohort…
  • « Previous Page
  • 1
  • …
  • 52
  • 53
  • 54
  • 55
  • 56
  • …
  • 186
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley